• NEBANNER

Chinese wholesale Aripiprazole For Sleep - 2′-Methoxy-3′-nitro-biphenyl-3-carboxylic acid – JIN DUN

Chinese wholesale Aripiprazole For Sleep - 2′-Methoxy-3′-nitro-biphenyl-3-carboxylic acid – JIN DUN

Short Description:


Product Detail

Product Tags

Related Video

Feedback (2)

Our eternal pursuits are the attitude of "regard the market, regard the custom, regard the science" as well as the theory of "quality the basic, have confidence in the very first and management the advanced" for Wastewater Treatment Steps, Surface Coating Is Suitable To Maintain, Analgesia For Nerve Pain, We are very proud of the good reputation from our customers for our products' reliable quality.
Chinese wholesale Aripiprazole For Sleep - 2′-Methoxy-3′-nitro-biphenyl-3-carboxylic acid – JIN DUN Detail:

2′-Methoxy-3′-nitro-biphenyl-3-carboxylic acid is used as the intermediate of Eltrombopag .
Eltrombopag, developed by GlaxoSmithKline (GSK) in the UK and later jointly developed with Novartis in Switzerland, is the first and only approved small molecule non peptide TPO receptor agonist in the world. Eltrombopag was approved by the US FDA in 2008 for the treatment of idiopathic thrombocytopenic purpura (ITP), and in 2014 for the treatment of severe aplastic anemia (AA). It is also the first drug approved by the US FDA for the treatment of AA in recent 30 years.
In december2012, the US FDA approved Eltrombopag for the treatment of thrombocytopenia in patients with chronic hepatitis C (CHC), so that hepatitis C patients with poor prognosis due to low platelet count can start and maintain interferon based standard therapy for liver diseases. On february3,2014, GlaxoSmithKline announced that the FDA granted the breakthrough treatment drug qualification of Eltrombopag for the treatment of hemopenia in patients with severe chemicalbook aplastic anemia (SAA) who did not fully respond to immunotherapy. On August 24, 2015, the US FDA approved Eltrombopag for the treatment of thrombocytopenia in adults and children aged 1 year and over with chronic immune thrombocytopenia (ITP) who have insufficient response to corticosteroids, immunoglobulins or splenectomy. On january4,2018, Eltrombopag was approved to be listed in China for the treatment of primary immune thrombocytopenia (ITP).


Product detail pictures:

Chinese wholesale Aripiprazole For Sleep - 2′-Methoxy-3′-nitro-biphenyl-3-carboxylic acid – JIN DUN detail pictures


Related Product Guide:

Our improvement depends on the superior equipment, excellent talents and continuously strengthened technology forces for Chinese wholesale Aripiprazole For Sleep - 2′-Methoxy-3′-nitro-biphenyl-3-carboxylic acid – JIN DUN , The product will supply to all over the world, such as: Cambodia, Egypt, Italy, With all these supports, we can serve every customer with quality product and timely shipping with highly responsibility. Being a young growing company, we might not the best, but we are trying our best to be your good partner.
  • The after-sale warranty service is timely and thoughtful, encounter problems can be resolved very quickly, we feel reliable and secure.
    5 Stars By Eudora from Poland - 2018.06.09 12:42
    The sales manager is very patient, we communicated about three days before we decided to cooperate, finally, we are very satisfied with this cooperation!
    5 Stars By Claire from Argentina - 2018.05.13 17:00
    Write your message here and send it to us